Stockreport

MicroVention Announces FDA Premarket Approval of a New Flow Diverter for the Treatment of Brain Aneurysms

TERUMO CORP UNSP/ADR  (TRUMY) 
NASDAQ:AMEX Investor Relations: terumo.com/investor/library/index.html
PDF ALISO VIEJO, Calif., Jan. 9, 2020 /PRNewswire/ -- MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neurovascular company announced the FDA Premarket Ap [Read more]